Summary Panel Discussion: Exploring ADC Clinical Performance & Improving Clinical Design to Reach Meaningful Patient Benefit for ADCs

Join the clinical and medical presenters to review the key learnings from the scientific programme days. Be sure to bring any questions across ADC clinical development strategy, dose escalation, biomarker-driven development, and ADC sequencing.

Speakers:

Venkatesh Pilla Reddy

Senior Director, Global PK/PD & Pharmacometrics

Eli Lilly & Co.